Utah Medical Products Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Utah Medical Products heeft een totaal eigen vermogen van $124.2M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $129.7M en $5.5M. De EBIT Utah Medical Products is $17.1M waardoor de rentedekking -5.6 is. Het heeft contanten en kortetermijnbeleggingen van $88.5M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
Rente dekkingsratio | -5.6x |
Contant | US$88.45m |
Aandelen | US$124.20m |
Totaal verplichtingen | US$5.50m |
Totaal activa | US$129.69m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Aug 06Utah Medical Products: An Attractive, But Speculative, Prospect
Mar 22Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Feb 09Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Dec 13Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Nov 23Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30
Nov 03Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295
Aug 28Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?
Mar 04Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295
Feb 10A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)
Jan 11Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29
Aug 08Utah Medical Products declares $0.29 dividend
Aug 02Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M
Jul 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
May 14Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29
Feb 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
Feb 12Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital
Sep 28Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28
Aug 06Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation
May 01Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?
Mar 26Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
Mar 02Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 11Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain
Jan 27Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?
Jan 13Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?
Dec 29Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?
Dec 15Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?
Nov 30Utah Medical Products declares $0.285 dividend
Nov 03Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $101.7M ) UTMD } overtreffen de korte termijn passiva ( $3.4M ).
Langlopende schulden: De kortetermijnactiva UTMD ( $101.7M ) overtreffen de langetermijnschulden ( $2.1M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: UTMD is schuldenvrij.
Schuld verminderen: UTMD had 5 jaar geleden geen schulden.
Schuldendekking: UTMD heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.
Rentedekking: UTMD heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.